Biologics News

CHICAGO — Gastrocnemius recession can be helpful in some cases for the treatment of patients with chronic Achilles tendinopathy, according to a presenter here.

Wright Medical Group recently announced that Kevin D. Cordell was appointed president of U.S. extremities, effective Sept. 29, 2014. Cordell will be responsible for operations for the Wright Medical U.S. extremities and biologic business and will report to the chief operating officer.

Cerapedics announced it has filed a Premarket Approval Application (PMA) with the U.S. Food and Drug Administration for i-FACTOR Peptide Enhanced Bone Graft.

Recently published study data demonstrated little evidence linking clinical and radiologic outcomes following matrix-induced autologous chondrocyte implantation to treat chondral defects of the knee, according to researchers.

Orthopedics Today has highlighted eight important stories to keep your practice up-to-date regarding rotator cuff tear fixation.

Spine Surgery Today features the seven stories deemed the most important to emerge from the International Spine Intervention Society Annual Meeting.

DSM has announced the launch of its new autologous cellular therapy development service.

ORLANDO, Fla. — Platelet-rich rich plasma injection appeared to be a promising therapy for patients who exhibited intradiscal back pain, according to study findings presented here.

ORLANDO, Fla. — Platelet-rich rich plasma injection appeared to be a promising therapy for patients who exhibited intradiscal back pain, according to study findings presented here.

AMSTERDAM — A multicenter, double-blind, randomized, placebo-controlled trial examining the use of platelet-rich plasma injections in athletes for the treatment of acute hamstring injuries has shown the injections were no more effective than placebo.